乙型肝炎病毒感染合并非酒精性脂肪性肝病 : 相互作用和预后。
关键词: AVT, antiviral therapy Antiviral efficacy BMI, body mass index CHB, chronic hepatitis B CI, confidence interval ETV, entecavir HBV infection HBV, hepatitis B virus HBeAg, hepatitis B e antigen HBsAg, hepatitis B surface antigen HCC, hepatocellular carcinoma HDL, high-density lipoprotein HDL-C, high-density lipoprotein-cholesterol HR, hazard ratio HS, hepatis steatosis Hepatocellular carcinoma LDL-C, low-density lipoprotein cholesterol Liver fibrosis NA, nucleos(t)ide analogue NAFLD, nonalcoholic fatty liver disease NASH, nonalcoholic steatohepatitis NR, not reported Nonalcoholic fatty liver disease OR, odds ratio PEG-IFN, pegylated interferon TAF, tenofovir alafenamide TDF, tenofovir TLR4, Toll-Like Receptor 4 aHR, adjusted hazard ratio non-HDL-C, non-high-density lipoprotein-cholesterol
来 源: DOI:10.1016/j.heliyon.2023.e13113 PDF(Pubmed)